Lapatinib blocked SARS-CoV-2 cytopathic effect and viral infection as assessed by viral RNA accumulation, and prevented accumulation of N protein in MRC5 (human pulmonary fibroblast cell line) cells expressing ACE2 that were infected with SARS-CoV-245. The gene discussed is ACE2; the disease is viral infectious disease.